FdaApplication
NDA 021860
Identifiers
- fda_app_no: NDA021860
Properties
| Property | Value |
|---|---|
| applicant_name | ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD |
| application_type | NDA |
| approval_date | 2006-05-19 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SARAFEM | FLUOXETINE HYDROCHLORIDE | EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| SARAFEM | FLUOXETINE HYDROCHLORIDE | EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| SARAFEM | FLUOXETINE HYDROCHLORIDE | EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
3 products